Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the Elderly

NCT05398926 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: COVID-19 Vaccine (Vero cell), Inactivated

Sponsor

Sinovac Life Sciences Co., Ltd.